Key result
Primary percutaneous coronary intervention was associated with an improvement in left ventricular systolic function (GLPSS increase ≥ 10%) in 54% of STEMI patients at 1 month.
Why the study?
The study was conducted to assess the impact of primary PCI on left ventricular systolic function in patients with acute STEMI using speckle tracking echocardiography within 24 hours and 1 month after intervention.
Does primary PCI improve left ventricular systolic function as measured by global longitudinal strain at 1 month in patients with STEMI?
Cohort (n=50)
Does primary PCI improve left ventricular systolic function as measured by global longitudinal strain at 1 month in patients with STEMI?
Global longitudinal strain improves in over half of STEMI patients 1 month after primary PCI, and this recovery can be predicted by baseline biomarkers and echocardiographic parameters.
GLPSS recovery post-primary PCI in STEMI may aid risk stratification; leaves open causal effects and requires randomized confirmation.
This prospective cohort study was conducted on fifty patients presented with STEMI and underwent primary PCI to Assess the impact of primary percutaneous coronary intervention (Primary PCI) on the left ventricular (LV) systolic function in patients with Acute STEMI using speckle tracking Echocardiography within the first 24 hrs and within 1 month after performing PCI. All patients were evaluated by history taking, clinical examination, laboratory investigations and coronary angiography assessment with revascularization of the infarct-related artery (IRA). All patients had CCU admission for 3 days. Conventional 2D echocardiography was performed within 24 h of Primary PCI to assess LV Global longitudinal peak systolic strain (GLPSS). All patients had been discharged to home with the guidelines-based medical treatment including (DAPT, Atorvastatin, ACEIs, Beta blockers). GLPSS was re-assessed after 1 month. The patients were divided into two groups: improved and non-improved, according to the improvement of LV systolic function measured by GLPSS. Improvement is defined by increase of GLPSS ≥ 10%. Our study demonstrated Improvement of LV function was based on GLPSS and was observed in 54% of the patients. Peak cardiac troponin T level, Peak creatine phosphokinase levels (CPK), LV diastolic function, and baseline GLPSS were identified as independent predictors of recovery of LV function. The patients who showed improvement of GLPSS were associated with improvement of EF (using simpson method).
No takes yet. Share an insight, caveat, or question.
Montaser et al. (2020) conducted a cohort in STEMI (n=50). Primary percutaneous coronary intervention was evaluated on Improvement of LV systolic function (increase of GLPSS ≥ 10%). Primary percutaneous coronary intervention was associated with an improvement in left ventricular systolic function (GLPSS increase ≥ 10%) in 54% of STEMI patients at 1 month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: